Browse Drug Recalls
1,680 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 1,680 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 1,680 FDA drug recalls — Class III.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| Feb 21, 2020 | Sodium Chloride Ophthalmic Ointment USP, 5%, 3.5 g tubes, Manufactured by: A... | Presence of Particulate Matter: Brown spots observed on the inside of the tube of product, identi... | Class III | Akorn, Inc. |
| Feb 17, 2020 | Potassium Chloride Extended-Release Tablets USP, 10mEq (750mg), 1000-count b... | Failed Tablet/Capsules Specifications: Oversized tablets were found in one lot of Potassium Chlor... | Class III | Strides Pharma Science Limited |
| Feb 14, 2020 | Discount Drug Mart, Allergy Relief, Fexofenadine Hydrochloride Tablets, 180 m... | Labeling: Incorrect or Missing Lot and/or Expiration date. | Class III | AAA Pharmaceutical, Inc. |
| Feb 12, 2020 | TRAMADOL HYDROCHLORIDE Tablets, USP, 50 mg, Rx Only a)100-count bottles (NDC ... | Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets ... | Class III | Golden State Medical Supply Inc. |
| Feb 10, 2020 | Frovatriptan Succinate Tablets, 2.5mg, packaged in 1 blister card of 9 tablet... | Labeling: Incorrect or Missing Lot and/or Exp Date: Product incorrectly labeled with an expiratio... | Class III | Par Pharmaceutical Inc. |
| Feb 7, 2020 | Glycopyrrolate Injection, USP 4 mg per 20 mL (0.2 mg/mL), 20 mL Multiple Dose... | Failed Impurities/Degradation Specifications: elevated levels of Benzaldehyde impurity was found ... | Class III | AuroMedics Pharma LLC |
| Jan 29, 2020 | Clonidine Hydrochloride Tablets, USP 0.1mg, Rx Only, 100-count bottle, Manufa... | Failed Impurities/Degredation Specifications: This recall is initiated as a precautionary measure... | Class III | UNICHEM PHARMACEUTICALS USA INC |
| Jan 28, 2020 | Tramadol Hydrochloride Tablets USP CIV, 50 mg, packaged in a) 100-count bottl... | Labeling: Incorrect package insert - Patient leaflets for the specified lots of unscored tablets ... | Class III | Teva Pharmaceuticals USA |
| Jan 24, 2020 | Pioglitazone and Metformin Hydrochloride Tablets, USP 15 mg/500 mg, Rx Only, ... | Subpotent Drug: Out of specification assay result, below specification, for two lots of Pioglitaz... | Class III | Macleods Pharma Usa Inc |
| Jan 22, 2020 | Minocycline Hydrochloride Extended-Release Tablets, USP, 105 mg*, 30-count bo... | Failed Dissolution Specifications: low out of specification results for dissolution testing. | Class III | Ascend Laboratories LLC |
| Jan 20, 2020 | Montelukast Sodium Chewable Tablets, 5 mg, 90-count bottles, Rx Only, Manufac... | Failed Dissolution Specifications: testing revealed low out of specification result in one lot o... | Class III | Macleods Pharma Usa Inc |
| Jan 15, 2020 | Magnesium Chloride Injection, MAGNESIUM CHLORIDE 20% INJECTABLE, For IV Use,... | Lack of Assurance of Sterility | Class III | Fusion IV Pharmaceuticals, Inc. dba Axia Pharma... |
| Jan 14, 2020 | methylPREDNISolone Sodium Succinate For Injection, USP, 500 mg*/vial, Rx Only... | Labeling: Incorrect Instructions: Vial label incorrectly instructs healthcare professional to rec... | Class III | Hikma Pharmaceuticals USA Inc. |
| Jan 10, 2020 | Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.0... | CGMP Deviations: Out of specification test result observed during retrospective review of blend u... | Class III | Lupin Pharmaceuticals Inc. |
| Jan 7, 2020 | Eczema Skin Relief Lotion, 2% Colloidal Oatmeal Skin Protectant Lotion, NET W... | Microbial contamination of non-sterile product. | Class III | Sigan Industries Inc. |
| Dec 26, 2019 | Proparacaine Hydrochloride Ophthalmic Solution, USP, 0.5%, 15 mL per dropper ... | Chemical contamination; out of specification results obtained for equipment cleaning residue rins... | Class III | Akorn, Inc. |
| Dec 20, 2019 | PCA Skin Blemish Control Bar, 3.2 oz/90g, Salicylic acid 2% - Acne cleanser, ... | Superpotent Drug: Salicylic acid content is above the firm's specification. | Class III | Island Kinetics, Inc. d.b.a. CoValence Laborato... |
| Dec 16, 2019 | NORepinephrine Bitartrate 8 mg added to 500 mL 5% Dextrose Injection USP (16 ... | Subpotent Drug | Class III | Pharmedium Services, LLC |
| Dec 16, 2019 | NORepinephrine Bitartrate 8 mg added to 250 mL 5% Dextrose Injection USP (32 ... | Subpotent Drug | Class III | Pharmedium Services, LLC |
| Dec 16, 2019 | NORepinephrine Bitartrate 4 mg added to 250 mL 5% Dextrose Injection USP (16 ... | Subpotent Drug | Class III | Pharmedium Services, LLC |
| Dec 13, 2019 | Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx... | Failed Impurities/Degradation Specifications: Out-of-specification result observed in any other i... | Class III | Lupin Pharmaceuticals Inc. |
| Dec 13, 2019 | Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in 100-coun... | Failed Dissolution Specifications: High out of specification result observed at stability studies. | Class III | The Harvard Drug Group |
| Dec 10, 2019 | Memantine Hydrochloride Extended-release Capsules, 28mg, packaged in a) 90-co... | Failed Dissolution Specifications: High out of specification result observed at stability studies. | Class III | Lupin Pharmaceuticals Inc. |
| Dec 2, 2019 | Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle, Rx Only, For... | Discoloration: Market complaints of discoloration in Moxifloxacin Ophthalmic Solution. | Class III | AuroMedics Pharma LLC |
| Nov 25, 2019 | VCF Vaginal Contraceptive Foam, a) can, 13 applications per can, Net wt. 0.6 ... | Defective Delivery System: canister unit exhibiting propellant leakage or loss, rendering the pro... | Class III | Apothecus Pharmaceutical Corp. |
| Nov 20, 2019 | SURE 48hr Confidence Unscented Original Solid Anti-Perspirant & Deodorant Net... | Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient... | Class III | Idelle Labs |
| Nov 20, 2019 | SURE 48hr Confidence Regular Original Solid Anti-Perspirant & Deodorant Net W... | Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient... | Class III | Idelle Labs |
| Nov 20, 2019 | SURE 48hr Confidence Nourishing Coconut invisible solid Antiperspirant & Deod... | Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient... | Class III | Idelle Labs |
| Nov 20, 2019 | SURE 48 hr Confidence Unscented invisible solid Anti-Perspirant & Deodorant, ... | Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient... | Class III | Idelle Labs |
| Nov 15, 2019 | Clobetasol Propionate Foam (Emulsion Formulation), 0.05% a) 50 g pack (NDC 68... | Defective delivery system; product is not foaming or is coming out as liquid. | Class III | Glenmark Pharmaceuticals Inc., USA |
| Nov 15, 2019 | Clobetasol Propionate Foam, 0.05%, a) 50 g pack (NDC 68462-608-27) and b) 100... | Defective delivery system; product is not foaming or is coming out as liquid. | Class III | Glenmark Pharmaceuticals Inc., USA |
| Nov 15, 2019 | Timolol Maleate Sterile Opthalmic Solution,USP 0.25%, 5 mL, Rx Only, For Topi... | Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had... | Class III | Rising Pharmaceuticals, Inc. |
| Nov 15, 2019 | Colostat, Homeopathic Remedy, 1 fl. oz. (30 mL) per bottle, 20% Ethanol, Dist... | Labeling mix-up - Indications on product label are incorrect. | Class III | Grato Holdings, Inc. |
| Nov 15, 2019 | Timolol Maleate USP, 0.5%, 5 mL, Sterile Opthalmic Solution, Rx Only, For T... | Labeling: Label mix-up: A case of Timolol Maleate Sterile Ophthalmic solution USP 0.25%, 5ml, had... | Class III | Rising Pharmaceuticals, Inc. |
| Nov 11, 2019 | Amiodarone Hydrochloride Injection, USP, 150 mg per 3 mL (50 mg / mL), 3 mL S... | Crystallization: Presence of visible particulate matter. | Class III | AuroMedics Pharma LLC |
| Nov 11, 2019 | Amiodarone Hydrochloride Injection, USP, 450 mg per 9 mL (50 mg / mL), 9 mL S... | Crystallization: Presence of visible particulate matter. | Class III | AuroMedics Pharma LLC |
| Nov 11, 2019 | Amiodarone Hydrochloride Injection, USP, 900 mg per 18 mL (50 mg / mL), 18 mL... | Crystallization: Presence of visible particulate matter. | Class III | AuroMedics Pharma LLC |
| Nov 1, 2019 | Cefdinir for Oral Suspension USP, 250 mg/5mL,100 mL bottle, Rx only, Manufact... | Presence of Foreign substance: identified as a dead ant. | Class III | Lupin Pharmaceuticals Inc. |
| Nov 1, 2019 | Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manuf... | Presence of Foreign substance: identified as a dead ant. | Class III | Lupin Pharmaceuticals Inc. |
| Nov 1, 2019 | Cefdinir for Oral Suspension USP, 125 mg/5mL, packaged in a) 60 mL bottle (ND... | Presence of Foreign substance: identified as a dead ant. | Class III | Lupin Pharmaceuticals Inc. |
| Oct 22, 2019 | Atorvastatin Calcium Tablets, USP 40 mg*, 1,000 count bottles, Rx Only, Manuf... | Presence of Foreign Tablets/Capsules: a single tablet of Pravastatin 40 mg found in bottle of Ato... | Class III | Apotex Inc. |
| Oct 21, 2019 | PF-Succinylcholine Chloride Injection, USP 20 mg/mL (200 mg/10 mL), Rx Only, ... | Incorrect labeling: Incorrect or missing lot and/or exp date | Class III | Nephron Pharmaceuticals Corporation dba Nephron... |
| Oct 17, 2019 | Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Ste... | Labeling: Incorrect or missing package insert. | Class III | Sandoz Inc |
| Oct 17, 2019 | Neomycin and Polymyxin B Sulfates and Dexamethasone Ophthalmic Suspension, Rx... | Labeling: Incorrect or missing package insert. | Class III | Sandoz Inc |
| Oct 17, 2019 | Bimatoprost Ophthalmic Solution 0.03%, Rx Only, For Topical Application to th... | Labeling: Incorrect or missing package insert. | Class III | Sandoz Inc |
| Oct 16, 2019 | Isotretinoin Capsules, USP 10 mg. Rx Only, 3 Prescription Blister Packs of 10... | Failed Impurities/Degradation Specifications: Tretinoin levels slightly above specification limits. | Class III | Amneal Pharmaceuticals, Inc. |
| Oct 11, 2019 | Levetiracetam Injection, 500 mg/5mL, 10 single-use 5 mL vials, Rx only, Manuf... | Labeling: Incorrect or Missing Package Insert - the incorrect package insert version was attached. | Class III | X-Gen Pharmaceuticals Inc. |
| Oct 4, 2019 | Methylphenidate Hydrochloride Oral Solution 5mg per 5mL, 500 mL Bottle, Sugar... | Presence of Foreign Substance; Fiber particles. | Class III | KVK-Tech, Inc. |
| Oct 1, 2019 | Zentrip (meclizine Hydrochloride), 25 mg strips, 8-strips per box, Distribute... | Subpotent Drug | Class III | Sato Pharmaceutical Inc. |
| Oct 1, 2019 | WAL-DRAM 2 (meclizine Hydrochloride) 25 mg tablets, packaged in a) 12 count (... | Subpotent Drug | Class III | Sato Pharmaceutical Inc. |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.